News Release - March 12, 2009

Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor

Source: Mylan

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.